Cargando…

Pharmacist interventions for obesity: improving treatment adherence and patient outcomes

Obesity is currently a worldwide pandemic, with overweight (body mass index [BMI] ≥25 kg/m(2)) and obesity (BMI ≥30 kg/m(2)) estimated at 35% and 12% of the global adult population, respectively. According to data collected from the United States National Health and Nutrition Examination Survey, app...

Descripción completa

Detalles Bibliográficos
Autores principales: Jordan, Melanie A, Harmon, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741031/
https://www.ncbi.nlm.nih.gov/pubmed/29354522
http://dx.doi.org/10.2147/IPRP.S72206
_version_ 1783288131608379392
author Jordan, Melanie A
Harmon, Jonathan
author_facet Jordan, Melanie A
Harmon, Jonathan
author_sort Jordan, Melanie A
collection PubMed
description Obesity is currently a worldwide pandemic, with overweight (body mass index [BMI] ≥25 kg/m(2)) and obesity (BMI ≥30 kg/m(2)) estimated at 35% and 12% of the global adult population, respectively. According to data collected from the United States National Health and Nutrition Examination Survey, approximately 68.8% of US adults are overweight or obese. Additionally, a large burden of health care costs can be attributed directly to obesity as well as multiple, potentially preventable, comorbidities such as cancer, cardiovascular disease, and diabetes. As a result, national and international organizations, such as the US Centers for Disease Control and World Health Organization, have made halting the rise of the obesity epidemic a top priority. Pharmacists, commonly considered one of the most trustworthy and accessible health care professionals, are ideally situated to provide counseling for weight and lifestyle management. This review presents examples of pharmacist-led as well as collaborative practices that have been somewhat successful in educating and monitoring patient progress in attaining weight-loss goals. Common barriers and potential solutions to administration of lifestyle counseling and monitoring programs, such as limited pharmacist time and resources, lack of expertise and/or confidence in program administration, and patient perception and awareness, are also discussed.
format Online
Article
Text
id pubmed-5741031
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-57410312018-01-19 Pharmacist interventions for obesity: improving treatment adherence and patient outcomes Jordan, Melanie A Harmon, Jonathan Integr Pharm Res Pract Review Obesity is currently a worldwide pandemic, with overweight (body mass index [BMI] ≥25 kg/m(2)) and obesity (BMI ≥30 kg/m(2)) estimated at 35% and 12% of the global adult population, respectively. According to data collected from the United States National Health and Nutrition Examination Survey, approximately 68.8% of US adults are overweight or obese. Additionally, a large burden of health care costs can be attributed directly to obesity as well as multiple, potentially preventable, comorbidities such as cancer, cardiovascular disease, and diabetes. As a result, national and international organizations, such as the US Centers for Disease Control and World Health Organization, have made halting the rise of the obesity epidemic a top priority. Pharmacists, commonly considered one of the most trustworthy and accessible health care professionals, are ideally situated to provide counseling for weight and lifestyle management. This review presents examples of pharmacist-led as well as collaborative practices that have been somewhat successful in educating and monitoring patient progress in attaining weight-loss goals. Common barriers and potential solutions to administration of lifestyle counseling and monitoring programs, such as limited pharmacist time and resources, lack of expertise and/or confidence in program administration, and patient perception and awareness, are also discussed. Dove Medical Press 2015-07-08 /pmc/articles/PMC5741031/ /pubmed/29354522 http://dx.doi.org/10.2147/IPRP.S72206 Text en © 2015 Jordan and Harmon. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Review
Jordan, Melanie A
Harmon, Jonathan
Pharmacist interventions for obesity: improving treatment adherence and patient outcomes
title Pharmacist interventions for obesity: improving treatment adherence and patient outcomes
title_full Pharmacist interventions for obesity: improving treatment adherence and patient outcomes
title_fullStr Pharmacist interventions for obesity: improving treatment adherence and patient outcomes
title_full_unstemmed Pharmacist interventions for obesity: improving treatment adherence and patient outcomes
title_short Pharmacist interventions for obesity: improving treatment adherence and patient outcomes
title_sort pharmacist interventions for obesity: improving treatment adherence and patient outcomes
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741031/
https://www.ncbi.nlm.nih.gov/pubmed/29354522
http://dx.doi.org/10.2147/IPRP.S72206
work_keys_str_mv AT jordanmelaniea pharmacistinterventionsforobesityimprovingtreatmentadherenceandpatientoutcomes
AT harmonjonathan pharmacistinterventionsforobesityimprovingtreatmentadherenceandpatientoutcomes